Johnson & Johnson ACUVUE OASYS for ASTIGMATISM (senofilcon A) 38% soft contact lenses

Land: Singapur

Sprache: Englisch

Quelle: HSA (Health Sciences Authority)

Verfügbar ab:

Johnson & Johnson International (Singapore) Pte Ltd

Klasse:

Class B medical device

Hergestellt von:

Johnson & Johnson Vision Care, Inc.

Therapiebereich:

Ophthalmology

Anwendungsgebiete:

ACUVUE OASYS Brand Contact Lenses for ASTIGMATISM contain a UV Blocker to help protect against transmission of harmful UV radiation to the cornea and into the eye. It is indicated for the optical correction of visual acuity in phakic or aphakic persons with non-diseased eyes that are hyperopic or myopic and may have 10.00D or less of astigmatism. Eye Care Professionals may prescribe the lenses either for single-use disposable wear or frequent/planned replacement wear with cleaning, disinfection and scheduled replacement. ACUVUE® OASYS™ Brand Contact Lenses for ASTIGMATISM have been approved for daily and extended wear for up to 6 nights/7 days of continuous wear. The lenses are also indicated for therapeutic use as a bandage lens for acute and chronic ocular conditions. Lenses prescribed for therapeutic use may be worn for daily or extended wearing periods.

Produktbesonderheiten:

Device System Info:[Sterile Medical Device], Sterilized by moist heat; Models: ACUVUE OASYS Brand Contact Lenses for ASTIGMATISM with Hydraclear Plus (SPH Power: -9.00D to +6.00D; CYL Power: -0.75D, -1.25D, -1.75D, -2.25D, -2.75D; excluding plano) (Pack size: 1,2,3,5,6,10,12,20,24,30,60,90,180,360) (Trial size: 1,3 lenses) - ACUVUE OASYS Brand Contact Lenses for ASTIGMATISM

Berechtigungsdatum:

2012-09-13